AI
Thursday, April 23, 2009 12:43:23 PM
Actually I will go out on a limb and say Telaprevir (just it and not any possible followons from VRTX) never reaches 1 billion in annual peak sales, I would think it would be closer to 500 million than 1 billion. But of course they could come out and price it at 90k (or whatever that ridiculuously high figure was) and prove me wrong in year 3 or so 
.
.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
